发布求助
文献互助 智能选刊 最新文献

Important advances in oncology最新文献

筛选
英文 中文
Screening mammography in women 40 to 49 years of age: yes. 40 - 49岁女性的乳房x光筛查:是的。
Important advances in oncology Pub Date : 1995-01-01
D B Kopans
{"title":"Screening mammography in women 40 to 49 years of age: yes.","authors":"D B Kopans","doi":"","DOIUrl":"","url":null,"abstract":"","PeriodicalId":77172,"journal":{"name":"Important advances in oncology","volume":" ","pages":"231-41"},"PeriodicalIF":0.0,"publicationDate":"1995-01-01","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"","citationCount":null,"resultStr":null,"platform":"Semanticscholar","paperid":"18676998","PeriodicalName":null,"FirstCategoryId":null,"ListUrlMain":null,"RegionNum":0,"RegionCategory":"","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":"","EPubDate":null,"PubModel":null,"JCR":null,"JCRName":null,"Score":null,"Total":0}
引用次数: 0
Three-dimensional treatment planning and conformal radiation dose delivery. 三维治疗计划和适形辐射剂量的传递。
Important advances in oncology Pub Date : 1995-01-01
A S Lichter, R K Ten Haken
{"title":"Three-dimensional treatment planning and conformal radiation dose delivery.","authors":"A S Lichter,&nbsp;R K Ten Haken","doi":"","DOIUrl":"","url":null,"abstract":"<p><p>Three-dimensional treatment planning and conformal dose delivery have the potential to increase the effectiveness of radiation treatments. For the first time, it is possible to ensure that the intended target is being treated with the full, desired dose. By restricting the high dose region to conform more closely to the shape of the target, normal tissues receive a smaller percentage of the dose, allowing doses to be escalated to the target. New equipment, including multileaf collimators and computer-controlled treatment machines, along with faster and more sophisticated planning systems, are making 3-D planning and treatment delivery increasingly practical. The final impact of these new techniques on the ultimate outcome of a course of radiation will be ascertained through continuing clinical experience and through ongoing clinical trials.</p>","PeriodicalId":77172,"journal":{"name":"Important advances in oncology","volume":" ","pages":"95-109"},"PeriodicalIF":0.0,"publicationDate":"1995-01-01","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"","citationCount":null,"resultStr":null,"platform":"Semanticscholar","paperid":"18677005","PeriodicalName":null,"FirstCategoryId":null,"ListUrlMain":null,"RegionNum":0,"RegionCategory":"","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":"","EPubDate":null,"PubModel":null,"JCR":null,"JCRName":null,"Score":null,"Total":0}
引用次数: 0
Tamoxifen for the prevention of breast cancer: no. 他莫昔芬预防乳腺癌:否。
Important advances in oncology Pub Date : 1995-01-01
M W DeGregorio, J U Maenpaa, V J Wiebe
{"title":"Tamoxifen for the prevention of breast cancer: no.","authors":"M W DeGregorio,&nbsp;J U Maenpaa,&nbsp;V J Wiebe","doi":"","DOIUrl":"","url":null,"abstract":"<p><p>The tamoxifen chemoprevention trial in health women is ongoing in over 250 cancer treatment centers. The use of tamoxifen for the treatment of postmenopausal women with known breast cancer has been touted as a medical breakthrough by many physicians. However, the ongoing trial which enroll high-risk healthy women above the age of 34, has been controversial since its initiation in 1991. Congressional hearings, editorial, and statistical analyses concerning the scientific basis of the trial have emerged over the past year. This chapter presents the newest scientific facts, and speculates on the unknown risks of using tamoxifen as a chemopreventive in healthy women.</p>","PeriodicalId":77172,"journal":{"name":"Important advances in oncology","volume":" ","pages":"175-85"},"PeriodicalIF":0.0,"publicationDate":"1995-01-01","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"","citationCount":null,"resultStr":null,"platform":"Semanticscholar","paperid":"18676993","PeriodicalName":null,"FirstCategoryId":null,"ListUrlMain":null,"RegionNum":0,"RegionCategory":"","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":"","EPubDate":null,"PubModel":null,"JCR":null,"JCRName":null,"Score":null,"Total":0}
引用次数: 0
Chemoprevention of prostate cancer with finasteride. 非那雄胺对前列腺癌的化学预防作用。
Important advances in oncology Pub Date : 1995-01-01
I Thompson, P Feigl, C Coltman
{"title":"Chemoprevention of prostate cancer with finasteride.","authors":"I Thompson,&nbsp;P Feigl,&nbsp;C Coltman","doi":"","DOIUrl":"","url":null,"abstract":"","PeriodicalId":77172,"journal":{"name":"Important advances in oncology","volume":" ","pages":"57-76"},"PeriodicalIF":0.0,"publicationDate":"1995-01-01","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"","citationCount":null,"resultStr":null,"platform":"Semanticscholar","paperid":"18677003","PeriodicalName":null,"FirstCategoryId":null,"ListUrlMain":null,"RegionNum":0,"RegionCategory":"","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":"","EPubDate":null,"PubModel":null,"JCR":null,"JCRName":null,"Score":null,"Total":0}
引用次数: 0
Risk of lung cancer and passive smoking. 肺癌和被动吸烟的风险。
Important advances in oncology Pub Date : 1995-01-01
D Trichopoulos
{"title":"Risk of lung cancer and passive smoking.","authors":"D Trichopoulos","doi":"","DOIUrl":"","url":null,"abstract":"","PeriodicalId":77172,"journal":{"name":"Important advances in oncology","volume":" ","pages":"77-85"},"PeriodicalIF":0.0,"publicationDate":"1995-01-01","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"","citationCount":null,"resultStr":null,"platform":"Semanticscholar","paperid":"18677004","PeriodicalName":null,"FirstCategoryId":null,"ListUrlMain":null,"RegionNum":0,"RegionCategory":"","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":"","EPubDate":null,"PubModel":null,"JCR":null,"JCRName":null,"Score":null,"Total":0}
引用次数: 0
High-dose chemotherapy with autologous bone marrow transplantation for the treatment of breast cancer: yes. 自体骨髓移植大剂量化疗治疗乳腺癌:是的。
Important advances in oncology Pub Date : 1995-01-01
W P Peters
{"title":"High-dose chemotherapy with autologous bone marrow transplantation for the treatment of breast cancer: yes.","authors":"W P Peters","doi":"","DOIUrl":"","url":null,"abstract":"","PeriodicalId":77172,"journal":{"name":"Important advances in oncology","volume":" ","pages":"215-30"},"PeriodicalIF":0.0,"publicationDate":"1995-01-01","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"","citationCount":null,"resultStr":null,"platform":"Semanticscholar","paperid":"18676997","PeriodicalName":null,"FirstCategoryId":null,"ListUrlMain":null,"RegionNum":0,"RegionCategory":"","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":"","EPubDate":null,"PubModel":null,"JCR":null,"JCRName":null,"Score":null,"Total":0}
引用次数: 0
Screening mammography in women 40 to 49 years of age: no. 40至49岁女性的乳房x光筛查:没有。
Important advances in oncology Pub Date : 1995-01-01
C J Baines
{"title":"Screening mammography in women 40 to 49 years of age: no.","authors":"C J Baines","doi":"","DOIUrl":"","url":null,"abstract":"","PeriodicalId":77172,"journal":{"name":"Important advances in oncology","volume":" ","pages":"243-51"},"PeriodicalIF":0.0,"publicationDate":"1995-01-01","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"","citationCount":null,"resultStr":null,"platform":"Semanticscholar","paperid":"18676999","PeriodicalName":null,"FirstCategoryId":null,"ListUrlMain":null,"RegionNum":0,"RegionCategory":"","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":"","EPubDate":null,"PubModel":null,"JCR":null,"JCRName":null,"Score":null,"Total":0}
引用次数: 0
Detection of minimal residual disease in patients with lymphomas using the polymerase chain reaction. 利用聚合酶链反应检测淋巴瘤患者的微小残留病变。
Important advances in oncology Pub Date : 1994-01-01
J G Gribben, L M Nadler
{"title":"Detection of minimal residual disease in patients with lymphomas using the polymerase chain reaction.","authors":"J G Gribben,&nbsp;L M Nadler","doi":"","DOIUrl":"","url":null,"abstract":"","PeriodicalId":77172,"journal":{"name":"Important advances in oncology","volume":" ","pages":"117-29"},"PeriodicalIF":0.0,"publicationDate":"1994-01-01","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"","citationCount":null,"resultStr":null,"platform":"Semanticscholar","paperid":"19195469","PeriodicalName":null,"FirstCategoryId":null,"ListUrlMain":null,"RegionNum":0,"RegionCategory":"","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":"","EPubDate":null,"PubModel":null,"JCR":null,"JCRName":null,"Score":null,"Total":0}
引用次数: 0
Ondansetron: a specific serotonin antagonist for the prevention of chemotherapy-induced vomiting. 昂丹司琼:一种预防化疗引起呕吐的特异性血清素拮抗剂。
Important advances in oncology Pub Date : 1994-01-01
M G Kris
{"title":"Ondansetron: a specific serotonin antagonist for the prevention of chemotherapy-induced vomiting.","authors":"M G Kris","doi":"","DOIUrl":"","url":null,"abstract":"","PeriodicalId":77172,"journal":{"name":"Important advances in oncology","volume":" ","pages":"165-77"},"PeriodicalIF":0.0,"publicationDate":"1994-01-01","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"","citationCount":null,"resultStr":null,"platform":"Semanticscholar","paperid":"19195472","PeriodicalName":null,"FirstCategoryId":null,"ListUrlMain":null,"RegionNum":0,"RegionCategory":"","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":"","EPubDate":null,"PubModel":null,"JCR":null,"JCRName":null,"Score":null,"Total":0}
引用次数: 0
Treatment of early stage prostate cancer: radiotherapy. 早期前列腺癌的治疗:放疗。
Important advances in oncology Pub Date : 1994-01-01
G E Hanks
{"title":"Treatment of early stage prostate cancer: radiotherapy.","authors":"G E Hanks","doi":"","DOIUrl":"","url":null,"abstract":"<p><p>PATIENTS with T1/T2 prostate cancer are well served by external beam radiation. 1. T1/T2, N0, M0 PATIENTS: The 10-year outcome of N0 patients is equal to that obtained by radical prostatectomy in similar patients without the operative mortality or incontinence that accompanies the latter procedure. Ten-year cure has been confirmed by PSA studies in irradiated patients, while this has not yet been demonstrated in surgical patients. 2. T1, NX, M0 PATIENTS: After radiation therapy these patients show no excess mortality as long as 15 years after treatment, an outcome confirming a strict criteria of cure. 3. T2, NX PATIENTS: After radiation therapy, these patients show continuing excess mortality to 15 years, but most 15-year survivors are NED, again supporting the concept of long-term cure. 4. T1/T2 N+, M0 PATIENTS: We must have clinical trials in these patients that study the roles of radiation, androgen deprivation, and surgery. 5. Conformal treatment technology is improving the technical delivery and dose administered by radiation therapy and decreasing both the acute and late side effects of treatment. It remains to be proved whether the increased dose and accuracy will improve local control and cure as hoped.</p>","PeriodicalId":77172,"journal":{"name":"Important advances in oncology","volume":" ","pages":"225-39"},"PeriodicalIF":0.0,"publicationDate":"1994-01-01","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"","citationCount":null,"resultStr":null,"platform":"Semanticscholar","paperid":"18523935","PeriodicalName":null,"FirstCategoryId":null,"ListUrlMain":null,"RegionNum":0,"RegionCategory":"","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":"","EPubDate":null,"PubModel":null,"JCR":null,"JCRName":null,"Score":null,"Total":0}
引用次数: 0
首页 上一页 下一页 尾页
0
×
引用
GB/T 7714-2015
复制
MLA
复制
APA
复制
导出至
BibTeX EndNote RefMan NoteFirst NoteExpress
×
提示
您的信息不完整，为了账户安全，请先补充。
现在去补充
×
提示
您因"违规操作"
具体请查看互助需知
我知道了
×
提示
现在去查看 取消
×
提示
确定
请完成安全验证×
相关产品
×
本文献相关产品
联系我们：info@booksci.cn Book学术提供免费学术资源搜索服务，方便国内外学者检索中英文文献。致力于提供最便捷和优质的服务体验。 Copyright © 2023 布克学术 All rights reserved.
京ICP备2023020795号-1
ghs 京公网安备 11010802042870号
Book学术文献互助
Book学术文献互助群
群 号：604180095
Book学术官方微信